These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. Lanese DM, Conger JD. J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781 [Abstract] [Full Text] [Related]
5. Effects of atriopeptin III on isolated rat afferent and efferent arterioles. Lanese DM, Yuan BH, Falk SA, Conger JD. Am J Physiol; 1991 Dec; 261(6 Pt 2):F1102-9. PubMed ID: 1661082 [Abstract] [Full Text] [Related]
7. Protein kinase C and calcium channel activation as determinants of renal vasoconstriction by angiotensin II and endothelin. Takenaka T, Forster H, Epstein M. Circ Res; 1993 Oct; 73(4):743-50. PubMed ID: 8396506 [Abstract] [Full Text] [Related]
8. Synergistic effects of angiotensin and adenosine in the renal microvasculature. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Am J Physiol; 1994 Feb; 266(2 Pt 2):F227-39. PubMed ID: 8141324 [Abstract] [Full Text] [Related]
9. Afferent and efferent arteriolar vasoconstriction to angiotensin II and norepinephrine involves release of Ca2+ from intracellular stores. Inscho EW, Imig JD, Cook AK. Hypertension; 1997 Jan; 29(1 Pt 2):222-7. PubMed ID: 9039106 [Abstract] [Full Text] [Related]
10. Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. Lanese DM, Falk SA, Conger JD. Transplantation; 1994 Dec 27; 58(12):1371-8. PubMed ID: 7809931 [Abstract] [Full Text] [Related]
11. Efferent arterioles exclusively express the subtype 1A angiotensin receptor: functional insights from genetic mouse models. Harrison-Bernard LM, Monjure CJ, Bivona BJ. Am J Physiol Renal Physiol; 2006 May 27; 290(5):F1177-86. PubMed ID: 16332932 [Abstract] [Full Text] [Related]
12. Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. Imig JD, Deichmann PC. Am J Physiol; 1997 Aug 27; 273(2 Pt 2):F274-82. PubMed ID: 9277588 [Abstract] [Full Text] [Related]
13. Disparate effects of calcium antagonists on renal microcirculation. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Hypertens Res; 1996 Mar 27; 19(1):31-6. PubMed ID: 8829821 [Abstract] [Full Text] [Related]
14. Direct visualization of effects of endothelin on the renal microvasculature. Loutzenhiser R, Epstein M, Hayashi K, Horton C. Am J Physiol; 1990 Jan 27; 258(1 Pt 2):F61-8. PubMed ID: 2405711 [Abstract] [Full Text] [Related]
15. Vessel- and vasoconstrictor-dependent role of rho/rho-kinase in renal microvascular tone. Nakamura A, Hayashi K, Ozawa Y, Fujiwara K, Okubo K, Kanda T, Wakino S, Saruta T. J Vasc Res; 2003 Jan 27; 40(3):244-51. PubMed ID: 12902637 [Abstract] [Full Text] [Related]
19. Characterization of the renal microvascular actions of a new dopaminergic (DA1) agonist, YM435. Takenaka T, Forster H, Epstein M. J Pharmacol Exp Ther; 1993 Mar 27; 264(3):1154-9. PubMed ID: 8095547 [Abstract] [Full Text] [Related]
20. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Ohishi K, Carmines PK, Inscho EW, Navar LG. Am J Physiol; 1992 Nov 27; 263(5 Pt 2):F900-6. PubMed ID: 1332506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]